Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells

Current Cancer Drug Targets

Volumn 13, Issue 6, 2013, Pages 640-650

  Hahm, Eun Ryeong ^a   Singh, Shivendra V ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Atg5; Autophagy; Beclin1; Breast cancer; MCF 7; MDA MB 231; Withaferin A

Indexed keywords

ACRIDINE ORANGE; ACTIN; AUTOPHAGY PROTEIN 5; BECLIN 1; MICROTUBULE ASSOCIATED PROTEIN 1; TRYPAN BLUE; WITHAFERIN A;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER INHIBITION; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE REPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; RNA INTERFERENCE; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ETHNOPHARMACOLOGY; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MEDICINE, AYURVEDIC; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROTEIN TRANSPORT; TUMOR BURDEN; WITHANOLIDES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84888333005     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/15680096113139990039     Document Type: Article

References (44)

1. Garodia, P.; Ichikawa, H.; Malani, N.; Sethi, G.; Aggarwal, B. B. From ancient medicine to modern medicine: Ayurvedic concepts of health and their role in inflammation and cancer. J. Soc. Integr. Oncol. 2007, 5, 25-37.
2. Baliga, M. S. Triphala, Ayurvedic formulation for treating and preventing cancer: A review. J. Altern. Complement. Med. 2010, 16, 1301-1308.
3. Baliga, M. S.; Dsouza, J. J. Amla (Emblica officinalis Gaertn), a wonder berry in the treatment and prevention of cancer. Eur. J. Cancer Prev. 2011, 20, 225-239.
4. Devi, P. U.; Sharada, A. C.; Solomon, F. E. Antitumor and radiosensitizing effects of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma-180. Indian J. Exp. Biol. 1993, 31, 607-611.
5. Widodo, N.; Kaur, K.; Shrestha, B. G.; Takagi, Y.; Ishii, T.; Wadhwa, R.; Kaul, S. C. Selective killing of cancer cells by leaf extract of Ashwagandha: Identification of a tumor-inhibitory factor and the first molecular insights to its effect. Clin. Cancer Res. 2007, 13, 2298-2306.
6. Padmavathi, B.; Rath, P. C.; Rao, A. R.; Singh, R.P. Roots of Withania somnifera inhibit forestomach and skin carcinogenesis in mice. Evid. Based Complement. Alternat. Med. 2005, 2, 99-105.
7. Leyon, P. V.; Kuttan, G. Effect of Withania somnifera on B16F-10 melanoma induced metastasis in mice. Phytother. Res. 2004, 18, 118-122.
8. Mathur, R.; Gupta, S. K.; Singh, N.; Mathur, S.; Kochupillai, V.; Velpandian, T. Evaluation of the effect of Withania somnifera root extracts on cell cycle and angiogenesis. J. Ethnopharmacol. 2006, 105, 336-341.
9. Gupta, S. K.; Mohanty, I.; Talwar, K. K.; Dinda, A.; Joshi, S.; Bansal, P.; Saxena, A.; Arya, D. S. Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. Mol. Cell. Biochem. 2004, 260, 39-47.
10. Ahmad, M.; Saleem, S.; Ahmad, A. S.; Ansari, M. A.; Yousuf, S.; Hoda, M. N.; Islam, F. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum. Exp. Toxicol. 2005, 24, 137-147.
11. Panda, S.; Kar, A. Changes in thyroid hormone concentrations after administration of ashwagandha root extract to adult male mice. J. Pharm. Pharmacol. 1998, 50, 1065-1068.
12. Owais, M.; Sharad, K. S.; Shehbaz, A.; Saleemuddin, M. Antibacterial efficacy of Withania somnifera (Ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis. Phytomedicine 2005, 12, 229-235.
13. Rasool, M.; Varalakshmi, P. Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: An in vivo and in vitro study. Vascul. Pharmacol. 2006, 44, 406-410.
14. Shohat, B.; Joshua, H. Effect of withaferin A on ehrlich ascites tumor cells. II. Target tumor cell destruction in vivo by immune activation. Int. J. Cancer 1971, 8, 487-496.
15. Devi, P. U.; Kamath, R.; Rao, B. S. Radiosensitization of a mouse melanoma by withaferin A: in vivo studies. Indian J. Exp. Biol. 2000, 38, 432-437.
16. Manoharan, S.; Panjamurthy, K.; Menon, V. P.; Balakrishnan, S.; Alias, L. M. Protective effect of Withaferin-A on tumour formation in 7,12-dimethylbenz[a]anthracene induced oral carcinogenesis in hamsters. Indian J. Exp. Biol. 2009, 47, 16-23.
17. Stan, S. D.; Hahm, E. R.; Warin, R.; Singh, S. V. Withaferin A causes FOXO3a-and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res. 2008, 68, 7661-7669.
18. Srinivasan, S.; Ranga, R. S.; Burikhanov, R.; Han, S. S.; Chendil, D. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res. 2007, 67, 246-253.
19. Thaiparambil, J. T.; Bender, L.; Ganesh, T.; Kline, E.; Patel, P.; Liu, Y.; Tighiouart, M.; Vertino, P. M.; Harvey, R. D.; Garcia, A.; Marcus, A. I. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int. J. Cancer 2011, 129, 2744-2755.
20. Hahm, E. R.; Moura, M. B.; Kelley, E. E.; Van Houten, B.; Shiva, S.; Singh, S. V. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS One 2011, 6, e23354.
21. Mayola, E.; Gallerne, C.; Esposti, D. D.; Martel, C.; Pervaiz, S.; Larue, L.; Debuire, B.; Lemoine, A.; Brenner, C.; Lemaire, C. Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2. Apoptosis 2011, 16, 1014-1027.
22. Yang, E. S.; Choi, M. J.; Kim, J. H.; Choi, K. S.; Kwon, T. K. Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition. Chem. Biol. Interact. 2011, 190, 9-15.
23. Lee, T. J.; Um, H. J.; Mindo, S.; Park, J. W.; Choi, K. S.; Kwon, T. K. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radic. Biol. Med. 2009, 46, 1639-1649.
24. Gibson, S. B. A matter of balance between life and death: targeting reactive oxygen species (ROS)-induced autophagy for cancer therapy. Autophagy 2010, 6, 835-837.
25. Chen, N.; Karantza, V. Autophagy as a therapeutic target in cancer. Cancer Biol. Ther. 2011, 11, 157-168.
26. Xiao, D.; Vogel, V.; Singh, S. V. Benzyl isothiocyanate-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak. Mol. Cancer Ther. 2006, 5, 2931-2945.
27. Herman-Antosiewicz, A.; Johnson, D. E.; Singh, S. V. Sulforaphane causes autophagy to inhibit release of cytochrome c and apoptosis in human prostate cancer cells. Cancer Res. 2006, 66, 5828-5835.
28. Powolny, A.A.; Bommareddy, A.; Hahm, E. R.; Normolle, D. P.; Beumer, J. H.; Nelson, J. B.; Singh, S. V. Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer. J. Natl. Cancer Inst. 2011, 103, 571-584.
29. Xiao, D.; Srivastava, S. K.; Lew, K. L.; Zeng, Y.; Hershberger, P.; Johnson, C. S.; Trump, D. L.; Singh, S. V. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis. Carcinogenesis 2003, 24, 891-897.
30. Xiao, D.; Choi, S.; Johnson, D. E.; Vogel, V. G.; Johnson, C. S.; Trump, D. L.; Lee, Y. J.; Singh, S. V. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 2004, 23, 5594-5606.
31. Klionsky, D. J.; Abeliovich, H.; Agostinis, P.; Agrawal, D. K.; Aliev, G.; Askew, D. S.; Baba, M.; Baehrecke, E. H.; Bahr, B. A.; Ballabio, A.; Bamber, B. A.; Bassham, D. C.; Bergamini, E.; Bi, X.; Biard-Piechaczyk, M.; Blum, J. S.; Bredesen, D. E.; Brodsky, J. L.; Brumell, J. H.; Brunk, U. T.; et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008, 4, 151-175.
32. Kabeya, Y.; Mizushima, N.; Ueno, T.; Yamamoto, A.; Kirisako, T.; Noda, T.; Kominami, E.; Ohsumi, Y.; Yoshimori, T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19, 5720-5728.
33. Bjørkøy, G.; Lamark, T.; Brech, A.; Outzen, H.; Perander, M.; Overvatn, A.; Stenmark, H.; Johansen, T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 2005, 171, 603-614.
34. White, E. J.; Martin, V.; Liu, J. L.; Klein, S. R.; Piya, S.; Gomez-Manzano, C.; Fueyo, J.; Jiang, H. Autophagy regulation in cancer development and therapy. Am. J. Cancer Res. 2011, 1, 362-372.
35. Tasdemir, E.; Maiuri, M. C.; Galluzzi, L.; Vitale, I.; Djavaheri-Mergny, M.; D'Amelio, M.; Criollo, A.; Morselli, E.; Zhu, C.; Harper, F.; Nannmark, U.; Samara, C.; Pinton, P.; Vicencio, J. M.; Carnuccio, R.; Moll, U. M.; Madeo, F.; Paterlini-Brechot, P.; Rizzuto, R.; Szabadkai, G.; Pierron, G.; Blomgren, K.; Tavernarakis, N.; Codogno, P.; Cecconi, F.; Kroemer, G. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 2008, 10, 676-687.
36. Amaravadi, R. K.; Yu, D.; Lum, J. J.; Bui, T.; Christophorou, M. A.; Evan, G. I.; Thomas-Tikhonenko, A.; Thompson, C. B. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 2007, 117, 326-336.
37. Bommareddy, A.; Hahm, E. R.; Xiao, D.; Powolny, A. A.; Fisher, A. L.; Jiang, Y.; Singh, S. V. Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Res. 2009, 69, 3704-3712.
38. Tomic, T.; Botton, T.; Cerezo, M.; Robert, G.; Luciano, F.; Puissant, A.; Gounon, P.; Allegra, M.; Bertolotto, C.; Bereder, J. M.; Tartare-Deckert, S.; Bahadoran, P.; Auberger, P.; Ballotti, R.; Rocchi, S. Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis. 2011, 2, e199.
39. Yue, Z.; Jin, S.; Yang, C.; Levine, A. J.; Heintz, N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. USA 2003, 100, 15077-15082.
40. Kihara, A.; Kabeya, Y.; Ohsumi, Y.; Yoshimori, T. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep. 2001, 2, 330-335.
41. Pattingre, S.; Tassa, A.; Qu, X.; Garuti, R.; Liang, X. H.; Mizushima, N.; Packer, M.; Schneider, M. D.; Levine, B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122, 927-939.
42. Levine, B.; Yuan, J. Autophagy in cell death: an innocent convict? J. Clin. Invest. 2005, 115, 2679-2688.
43. Cao, Y.; Klionsky, D. J. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res. 2007, 17, 839-849.
44. Huang, S.; Yang, Z. J.; Yu, C.; Sinicrope, F. A. Inhibition of mTOR Kinase by AZD8055 Can Antagonize Chemotherapy-induced Cell Death through Autophagy Induction and Down-regulation of p62/Sequestosome 1. J. Biol. Chem. 2011, 286, 40002-40012.